Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2005-02-01 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE BLANC-MESNIL (93150), Seine-Saint-Denis
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES TILLEULS : revenue, balance sheet and financial ratios
PHARMACIE DES TILLEULS is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE BLANC-MESNIL (93150),
this company of category PME
shows in 2023 a net income positive of 467 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES TILLEULS (SIREN 480628577)
Indicator
2023
2022
2021
2020
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
467 406 €
674 472 €
743 390 €
328 716 €
322 618 €
274 868 €
143 152 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE DES TILLEULS generates positive net income of 467 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 143 k€ -> 467 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
467 406 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 86%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.42%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
85.846%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES TILLEULS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2020
2021
2022
2023
Debt ratio
87.853
62.356
43.406
7.267
3.458
3.978
0.42
Financial autonomy
46.197
53.435
61.466
82.811
80.073
84.91
85.846
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
0.422023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Excellent
In 2023, the debt ratio of PHARMACIE DES TILLEULS (0.42) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
85.85%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Excellent
In 2023, the financial autonomy of PHARMACIE DES TILLEULS (85.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 318.79. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
318.785
Liquidity indicators evolution PHARMACIE DES TILLEULS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2020
2021
2022
2023
Liquidity ratio
246.873
255.592
327.114
435.028
346.855
547.817
318.785
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
318.792023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Excellent
In 2023, the liquidity ratio of PHARMACIE DES TILLEULS (318.79) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE DES TILLEULS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DES TILLEULS is estimated at
5 515 145 €
(range 3 354 024€ - 7 753 057€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
3354k€5515k€7753k€
5 515 145 €Range: 3 354 024€ - 7 753 057€
NAF 5 année 2023
Valuation method used
Net Income Multiple
467 406 €
×
11.8x
=5 515 146 €
Range: 3 354 024€ - 7 753 058€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES TILLEULS with other companies in the same sector:
Frequently asked questions about PHARMACIE DES TILLEULS
What is the revenue of PHARMACIE DES TILLEULS ?
The revenue of PHARMACIE DES TILLEULS is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DES TILLEULS profitable?
Yes, PHARMACIE DES TILLEULS generated a net profit of 467 k€ in 2023.
Where is the headquarters of PHARMACIE DES TILLEULS ?
The headquarters of PHARMACIE DES TILLEULS is located in LE BLANC-MESNIL (93150), in the department Seine-Saint-Denis.
Where to find the tax return of PHARMACIE DES TILLEULS ?
The tax return of PHARMACIE DES TILLEULS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES TILLEULS operate?
PHARMACIE DES TILLEULS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart